The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
Open accessAbstract
Pleiotrophin (PTN) is a secreted growth factor that induces neurite outgrowth and is mitogenic for fibroblasts, epithelial, and endothelial cells. During tumor growth PTN can serve as an angiogenic factor and drive tumor invasion and metastasis. To identify a receptor for PTN, we panned a phage display human cDNA library against immobilized PTN protein as a bait. From this we isolated a phage insert that was homologous to an amino acid sequence stretch in the extracellular domain (ECD) of the orphan receptor tyrosine kinase anaplastic lymphoma kinase (ALK). In parallel with PTN, ALK is highly expressed during perinatal development of the nervous system and down-modulated in the adult. Here we show in cell-free assays as well as in radioligand receptor binding studies in intact cells that PTN binds to the ALK ECD with an apparent Kd of 32 +/- 9 pm. This receptor binding is inhibited by an excess of PTN, by the ALK ECD, and by anti-PTN and anti-ECD antibodies. PTN added to ALK-expressing cells induces phosphorylation of both ALK and of the downstream effector molecules IRS-1, Shc, phospholipase C-gamma, and phosphatidylinositol 3-kinase. Furthermore, the growth stimulatory effect of PTN on different cell lines in culture coincides with the endogenous expression of ALK mRNA, and the effect of PTN is enhanced by ALK overexpression. From this we conclude that ALK is a receptor that transduces PTN-mediated signals and propose that the PTN-ALK axis can play a significant role during development and during disease processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Autocrine growth factors and cancer
Sporn, M. B., & Roberts, A. B. (1985) · Nature · doi:10.1038/313745a0 · Cited by 1,438
Growth factor signaling by receptor tyrosine kinases
Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,430
Regulation of Phosphoinositide-specific Phospholipase C Isozymes
Rhee, S. G., & Bae, Y. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15045 · Cited by 876
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Self-citationWen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Self-citationPulford, K. A. F., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.4.1394 · Cited by 557
Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., & Witte, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201062 · Cited by 524
Li, Y.-S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J., & Deuel, T. F. (1990) · Science · doi:10.1126/science.2270483 · Cited by 474
IRS-1: Essential for Insulin- and IL-4-Stimulated Mitogenesis in Hematopoietic Cells
Wang, L.-M., Myers, M. G., Sun, X.-J., Aaronson, S. A., White, M., & Pierce, J. H. (1993) · Science · doi:10.1126/science.8372354 · Cited by 395
Rauvala, H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08443.x · Cited by 372
Bischof, D., Pulford, K., Mason, D. Y., & Morris, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2312 · Cited by 363
Autoregulatory Mechanisms in Protein-tyrosine Kinases
Hubbard, S. R., Mohammadi, M., & Schlessinger, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.11987 · Cited by 318
Maeda, N., Ichihara-Tanaka, K., Kimura, T., Kadomatsu, K., Muramatsu, T., & Noda, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12474 · Cited by 315
Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., & Yamamoto, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4181 · Cited by 289
Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3265 · Cited by 287
Bai, R.-Y., Dieter, P., Peschel, C., Morris, S. W., & Duyster, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6951 · Cited by 281
An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri, R., Zhang, H. T., Donnini, S., Ziche, M., & Bicknell, R. (1997) · PubMed · Cited by 279
Signal Transduction Through the EGF Receptor Transfected in IL-3-Dependent Hematopoietic Cells
Pierce, J. H., Ruggiero, M., Fleming, T. P., Di Fiore, P. P., Greenberger, J. S., Varticovski, L., Schlessinger, J., Rovera, G., & Aaronson, S. A. (1988) · Science · doi:10.1126/science.3257584 · Cited by 226
Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., & Wellstein, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35692-8 · Cited by 219
Self-citationSchulte, A. M., Lai, S., Kurtz, A., Czubayko, F., Riegel, A. T., & Wellstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14759 · Cited by 203
Self-citationCzubayko, F., Schulte, A. M., Berchem, G. J., & Wellstein, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14753 · Cited by 162
Self-citationYeh, H.-J., He, Y. Y., Xu, J., Hsu, C. Y., & Deuel, T. F. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03699.1998 · Cited by 143
Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.
Chauhan, A. K., Li, Y. S., & Deuel, T. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.679 · Cited by 138
EGF Receptor and erb B-2 Tyrosine Kinase Domains Confer Cell Specificity for Mitogenic Signaling
Fiore, P. P. D., Segatto, O., Taylor, W. G., Aaronson, S. A., & Pierce, J. H. (1990) · Science · doi:10.1126/science.2181668 · Cited by 137
Wellstein, A., Fang, W. J., Khatri, A., Lu, Y., Swain, S. M., Dickson, R. B., Sasse, J., Riegel, A. T., & Lippman, M. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45920-0 · Cited by 130
Self-citationMitogenic properties of a new endothelial cell growth factor related to pleiotrophin
Courty, J., Dauchel, M. C., Caruelle, D., Perderiset, M., & Barritault, D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81267-7 · Cited by 123
Kojima, T., Katsumi, A., Yamazaki, T., Muramatsu, T., Nagasaka, T., Ohsumi, K., & Saito, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5914 · Cited by 116
Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko, F., Riegel, A. T., & Wellstein, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31970-1 · Cited by 94
Self-citationHuman Breast Cancer Growth Inhibited in Vivo by a Dominant Negative Pleiotrophin Mutant
Zhang, N., Zhong, R., Wang, Z., & Deuel, T. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16733 · Cited by 83
Souttou, B., Juhl, H. H., Clark, J. H., Röckseisen, M., Klomp, H.-J., Raulais, D., Vigny, M., & Wellstein, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1468 · Cited by 75
Self-citationSignal Transduction Pathways Involved in the Mitogenic Activity of Pleiotrophin
Souttou, B., Ahmad, S., Riegel, A. T., & Wellstein, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19588 · Cited by 70
Self-citationWellmann, A., Doseeva, V., Butscher, W. G., Raffeld, M. A., Fukushima, P. I., Stetler‐Stevenson, M., & Gardner, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337149 · Cited by 69
Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber, D., Klomp, H.-J., Czubayko, F., Wellstein, A., & Juhl, H. H. (2000) · PubMed · Cited by 65
Self-citationUeno, H., Hirano, N., Kozutsumi, H., Sasaki, K., Tanaka, T., Yazaki, Y., & Hirai, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20135 · Cited by 37
Ueno, H., Sasaki, K., Kozutsumi, H., Miyagawa, K., Mitani, K., Yazaki, Y., & Hirai, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27707 · Cited by 20
Cited by
The anaplastic lymphoma kinase in the pathogenesis of cancer
Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2291 · Cited by 882
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg, B., & Palmer, R. H. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3580 · Cited by 645
The SELDI-TOF MS Approach to Proteomics: Protein Profiling and Biomarker Identification
Issaq, H. J., Veenstra, T. D., Conrads, T. P., & Felschow, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6678 · Cited by 538
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Muramatsu, T. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003231 · Cited by 405
Metadata
- Authors
- Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., & Wellstein, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 276
- Issue
- 20
- Pages
- 16772-16779
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2099784353
- Cited by
- 382
- References
- 37
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.